NASDAQ: BLRX
Biolinerx Ltd Stock Ownership - Who owns Biolinerx?

Insider buying vs selling

Have Biolinerx Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLRX insiders and whales buy or sell their stock.

BLRX Shareholders

What type of owners hold Biolinerx Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rhumbline Advisers0.00%3,353$9.82kInstitution
Citigroup Inc0.00%2,038$5.97kInstitution
Ubs Group Ag0.00%1,951$5.72kInstitution
Wells Fargo Company0.00%1,750$5.13kInstitution
Bnp Paribas Financial Markets0.00%1,500$4.40kInstitution
Nemes Rush Group LLC0.00%250$732.50Institution
Morgan Stanley0.00%100$293.00Institution
Danske Bank A0.00%2$5.86Institution
Banque Cantonale Vaudoise0.00%1$2.93Institution

1 of 1

BLRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLRX0.00%0.00%
HOTH5.54%52.08%Net Selling
QCLS4.83%95.17%
CRIS5.50%94.50%
TRAW0.74%99.26%

Biolinerx Stock Ownership FAQ

Who owns Biolinerx?

Biolinerx (NASDAQ: BLRX) is owned by 0.00% institutional shareholders, 0.00% Biolinerx insiders, and 100.00% retail investors. Rhumbline Advisers is the largest individual Biolinerx shareholder, owning 3353.00 shares representing 0.00% of the company. Rhumbline Advisers's Biolinerx shares are currently valued at $9.42k.

If you're new to stock investing, here's how to buy Biolinerx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.